Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.48 - $2.03 $6,204 - $26,241
-12,927 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.76 - $4.84 $5,459 - $15,013
-3,102 Reduced 19.35%
12,927 $27,000
Q3 2021

Nov 15, 2021

SELL
$8.86 - $17.05 $149,051 - $286,832
-16,823 Reduced 51.21%
16,029 $149,000
Q2 2021

Aug 16, 2021

BUY
$3.75 - $78.5 $123,195 - $2.58 Million
32,852 New
32,852 $592,000

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0

About Brooklyn ImmunoTherapeutics, Inc.


  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.